1. Home
  2. NOA vs PBYI Comparison

NOA vs PBYI Comparison

Compare NOA & PBYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NOA

North American Construction Group Ltd. (no par)

HOLD

Current Price

$13.43

Market Cap

349.9M

ML Signal

HOLD

Logo Puma Biotechnology Inc

PBYI

Puma Biotechnology Inc

HOLD

Current Price

$9.27

Market Cap

413.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOA
PBYI
Founded
1953
2010
Country
Canada
United States
Employees
N/A
N/A
Industry
Meat/Poultry/Fish
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
349.9M
413.3M
IPO Year
2006
2011

Fundamental Metrics

Financial Performance
Metric
NOA
PBYI
Price
$13.43
$9.27
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
56.1K
286.1K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
2.40%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.08
Revenue
N/A
$27,685,000.00
Revenue This Year
$14.77
N/A
Revenue Next Year
$5.43
N/A
P/E Ratio
$18.05
$114.00
Revenue Growth
N/A
N/A
52 Week Low
$12.07
$4.30
52 Week High
$17.26
$9.51

Technical Indicators

Market Signals
Indicator
NOA
PBYI
Relative Strength Index (RSI) 43.79 62.07
Support Level $12.97 $7.44
Resistance Level $14.51 $9.40
Average True Range (ATR) 0.55 0.42
MACD -0.12 0.04
Stochastic Oscillator 3.68 82.42

Price Performance

Historical Comparison
NOA
PBYI

About NOA North American Construction Group Ltd. (no par)

North American Construction Group Ltd is Canada's heavy civil construction and mining contractor provider. The company has provided services to oil, natural gas, and resource companies. The Company provides a wide range of mining and heavy civil construction services to customer in the resource development and industrial construction sectors within Canada, the United States, and Australia. The Company's reportable segments are Heavy Equipment Canada, Heavy Equipment Australia, and Other. Heavy Equipment Canada and Heavy Equipment Australia include all of aspects of the mining and heavy civil construction services provided within those geographic areas. Other includes mine management contract work in the United States, its external maintenance and rebuild programs.

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Share on Social Networks: